Liver injury in sepsis: manifestations, mechanisms and emerging therapeutic strategies

被引:0
作者
Xu, Xinqi [1 ,2 ]
Yang, Tingyu [1 ,2 ]
An, Jiapan [1 ,2 ]
Li, Bin [1 ,2 ,3 ]
Dou, Zhimin [1 ,2 ,3 ]
机构
[1] Lanzhou Univ, Hosp 1, Lanzhou, Peoples R China
[2] Lanzhou Univ, Sch Clin Med 1, Lanzhou, Peoples R China
[3] Lanzhou Univ, Hosp 1, Dept Crit Care Med, Lanzhou, Peoples R China
关键词
sepsis; liver injury; inflammation; oxidative stress; pyroptosis; autophagy; noncoding regulation; INFLAMMASOME ACTIVATION; NLRP3; INFLAMMASOME; HYPOXIC HEPATITIS; OXIDATIVE STRESS; INNATE IMMUNE; PYROPTOSIS; CELLS; MELATONIN; ENDOTOXEMIA; MACROPHAGES;
D O I
10.3389/fimmu.2025.1575554
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sepsis is defined as a condition related to infection that manifests with multiorgan dysfunction, representing a life-threatening state. Consequently, severe complications frequently occur, with liver injury being one of the most prevalent serious complications of sepsis. Liver dysfunction during sepsis serves as an independent predictor of mortality. This review provides a comprehensive overview of current research on sepsis-induced liver injury (SILI), encompassing the clinical manifestations, diagnostic criteria, pathogenesis and therapeutic strategies associated with this condition. SILI may manifest as hypoxic hepatitis due to ischemia and shock, cholestasis resulting from abnormal bile metabolism, or bile duct sclerosis. The pathophysiology of sepsis involves intricate interactions among the inflammatory response, oxidative stress, and cell death. All of these factors complicate treatment and represent potential targets for therapeutic intervention. Furthermore, this review addresses the limitations inherent in conventional therapies currently employed for managing SILI and emphasizes the potential of novel targeted strategies aimed at addressing the fundamental mechanisms underlying this condition.
引用
收藏
页数:14
相关论文
共 161 条
[1]   Hypoxic hepatitis - its biochemical profile, causes and risk factors of mortality in critically-ill patients: A cohort study of 565 patients [J].
Aboelsoud, Mohammed M. ;
Javaid, Amen I. ;
Al-Qadi, Mazen O. ;
Lewis, James H. .
JOURNAL OF CRITICAL CARE, 2017, 41 :9-15
[2]   Usefulness of Antioxidants as Adjuvant Therapy for Septic Shock: A Randomized Clinical Trial [J].
Aisa-Alvarez, Alfredo ;
Soto, Maria Elena ;
Guarner-Lans, Veronica ;
Camarena-Alejo, Gilberto ;
Franco-Granillo, Juvenal ;
Martinez-Rodriguez, Enrique A. ;
Gamboa Avila, Ricardo ;
Manzano Pech, Linaloe ;
Perez-Torres, Israel .
MEDICINA-LITHUANIA, 2020, 56 (11) :1-15
[3]   Pharmacological Inhibition of FAK-Pyk2 Pathway Protects Against Organ Damage and Prolongs the Survival of Septic Mice [J].
Alves, Gustavo Ferreira ;
Aimaretti, Eleonora ;
Einaudi, Giacomo ;
Mastrocola, Raffaella ;
de Oliveira, Junior Garcia ;
Collotta, Debora ;
Porchietto, Elisa ;
Aragno, Manuela ;
Cifani, Carlo ;
Sordi, Regina ;
Thiemermann, Christoph ;
Fernandes, Daniel ;
Collino, Massimo .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[4]   LncRNA CASC9 enhances the stability of SOCS-1 by combining with FUS to alleviate sepsis-induced liver injury [J].
Bai, Jinquan ;
Chen, Shiyi .
CYTOKINE, 2023, 171
[5]   The liver in sepsis: molecular mechanism of liver failure and their potential for clinical translation [J].
Beyer, Dustin ;
Hoff, Jessica ;
Sommerfeld, Oliver ;
Zipprich, Alexander ;
Gassler, Nikolaus ;
Press, Adrian T. .
MOLECULAR MEDICINE, 2022, 28 (01)
[6]   Melatonin for the treatment of sepsis: the scientific rationale [J].
Biancatelli, Ruben Manuel Luciano Colunga ;
Berrill, Max ;
Mohammed, Yassen H. ;
Marik, Paul E. .
JOURNAL OF THORACIC DISEASE, 2020, 12 :S54-S65
[7]   Epigenetics of Sepsis [J].
Binnie, Alexandra ;
Tsang, Jennifer L. Y. ;
Hu, Pingzhao ;
Carrasqueiro, Gabriela ;
Castelo-Branco, Pedro ;
dos Santos, Claudia C. .
CRITICAL CARE MEDICINE, 2020, 48 (05) :745-756
[8]   ISCHEMIC HEPATITIS [J].
BYNUM, TE ;
BOITNOTT, JK ;
MADDREY, WC .
DIGESTIVE DISEASES AND SCIENCES, 1979, 24 (02) :129-135
[9]   Mesenchymal stem cell-derived exosome alleviates sepsis- associated acute liver injury by suppressing MALAT1 through microRNA-26a-5p: an innovative immunopharmacological intervention and therapeutic approach for sepsis [J].
Cai, Jizhen ;
Tang, Da ;
Hao, Xiao ;
Liu, Enyi ;
Li, Wenbo ;
Shi, Jian .
FRONTIERS IN IMMUNOLOGY, 2023, 14
[10]   Inflammasome signaling and regulation of interleukin-1 family cytokines [J].
Chan, Amy H. ;
Schroder, Kate .
JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 217 (01)